In this study, we aimed to elucidate the molecular mechanisms and networks affected by the antiviral MX2 gene, previously reported to have tumor‐suppressive features in melanoma partially through negative modification of AKT activity, cell cycle, and tumor growth. The gene discussed is AKT1; the disease is melanoma.